Page 2,938«..1020..2,9372,9382,9392,940..2,9502,960..»

Category Archives: Transhuman News

DNA pioneer to sell Nobel Prize

Posted: November 26, 2014 at 1:47 pm

By Bryony Jones, CNN

updated 8:24 AM EST, Wed November 26, 2014

STORY HIGHLIGHTS

(CNN) -- DNA pioneer James Watson is to sell the Nobel Prize he won for his co-discovery of the double helix structure, the building block of life.

The coveted gold medal is expected to go under the hammer for up to $3.5 million in a sale at Christie's in New York on December 4.

It will be the first time a Nobel Prize has been sold by a living recipient.

Watson, now 85, was awarded the medal for work in the field of physiology or medicine alongside fellow scientists Francis Crick and Maurice Wilkins in 1962.

Nobel Peace Prize: They didn't win either

Nobel Peace Prize: They didn't win either

Nobel Peace Prize: They didn't win either

Original post:
DNA pioneer to sell Nobel Prize

Posted in DNA | Comments Off on DNA pioneer to sell Nobel Prize

James Watson's Nobel Prize for DNA work going on auction block

Posted: at 1:47 pm

NEW YORK, Nov. 25 (UPI) -- James Watson will become the first living Nobel laureate to sell his prize when the gold medal he was awarded for the discovery of DNA structure is auctioned in New York.

The prize could sell for as much as $3.5 million next week at Christie's in New York. Watson plans to use the proceeds to fund scientific research.

Watson, a native of Chicago, was a young researcher at the Cavendish Laboratory at Cambridge University in England when he met his collaborator, Francis Crick. He told CNN in a 2013 interview that Crick was the first person he met who shared his conviction of the importance of DNA.

Within a short time, they determined that DNA, the protein that forms genes, has a double helix structure.

"All we could say when we got it: It's so beautiful!" Watson said. "DNA was my only gold rush."

Watson, Crick and Maurice Wilkins of King's College in London, who had made important contributions in DNA research, were awarded the Nobel Prize in physiology and medicine in 1962.

Watson's notes for his acceptance speech and the manuscript of the lecture are also to be sold.

Crick died in 2004. A letter he wrote his son, Secret of Life, which explained the DNA structure days before the official announcement of the discovery, was sold last year for a record $6.06 million.

Watson, 86, is chancellor emeritus of the Cold Spring Harbor Laboratory in New York State. He said in a statement that the money from the sale would help him "in keeping the academic world an environment where great ideas and decency prevail."

"I look forward to making further philanthropic gifts to Cold Spring Harbor Laboratory, the University of Chicago, and Clare College Cambridge," he said.

Read more:
James Watson's Nobel Prize for DNA work going on auction block

Posted in DNA | Comments Off on James Watson's Nobel Prize for DNA work going on auction block

An enzyme that fixes broken DNA sometimes destroys it instead, Stanford researchers find

Posted: at 1:47 pm

PUBLIC RELEASE DATE:

26-Nov-2014

Contact: Rosanne Spector manishma@stanford.edu 650-725-5374 Stanford University Medical Center @sumedicine

Enzymes inside cells that normally repair damaged DNA sometimes wreck it instead, researchers at the Stanford University School of Medicine have found. The insight could lead to a better understanding of the causes of some types of cancer and neurodegenerative disease.

In a paper to be published online Nov. 27 in Molecular Cell, the researchers explain how the recently discovered mechanism of DNA damage occurs when genetic transcripts, composed of RNA, stick to the DNA instead of detaching from it.

Certain enzymes, called endonucleases, are attracted to DNA/RNA hybrids that form when gene transcription goes awry -- and they cut the DNA like scissors to damage it.

The researchers conducted the study with human cells in culture, using molecular biology techniques to turn off specific genes. This allowed them to induce cells to form the hybrids and to see what would happen when various enzymes were inhibited.

"What we found is when we get rid of these endonucleases, we don't see the damage," said Karlene Cimprich, PhD, professor of chemical and systems biology and the paper's senior author. "When those nucleases are present, they cut the DNA in the hybrid."

Both helpful and harmful

What's really interesting, said Cimprich, is these same enzymes are noted for fixing DNA damage. "They take part in the repair of DNA lesions from sunlight and certain chemicals, like those found in cigarette smoke," she said. The structures formed by the hybrid of RNA and DNA are similar to those formed in cells damaged by ultraviolet light.

Visit link:
An enzyme that fixes broken DNA sometimes destroys it instead, Stanford researchers find

Posted in DNA | Comments Off on An enzyme that fixes broken DNA sometimes destroys it instead, Stanford researchers find

The Nightlife Genome Project – Video

Posted: at 1:46 pm


The Nightlife Genome Project
NightOwl Powered by The Nightlife Genome Project Your all-knowing personal assistant for finding the right drinking spot for any situation. Download NightOwl here: http://ow.ly/EBneO.

By: NightOwl

Read more:
The Nightlife Genome Project - Video

Posted in Genome | Comments Off on The Nightlife Genome Project – Video

Humanoid Opera – Paralyzed Genome (Live in The Cinema House Moscow) – Video

Posted: at 1:46 pm


Humanoid Opera - Paralyzed Genome (Live in The Cinema House Moscow)
Humanoid Opera - Paralyzed Genome (Live in The Cinema House Moscow) " " 2014.

By: Humanoid Opera

Go here to see the original:
Humanoid Opera - Paralyzed Genome (Live in The Cinema House Moscow) - Video

Posted in Genome | Comments Off on Humanoid Opera – Paralyzed Genome (Live in The Cinema House Moscow) – Video

Blind Scottish Centipede Genome Unlocks Evolutionary Secrets

Posted: at 1:46 pm

November 26, 2014

Image Caption: This is Strigamia maritima, the centipede species genetically sequenced in the study. Credit: Dr. Carlo Brena

Eric Hopton for redOrbit.com Your Universe Online

An international group of scientists has completed the first ever genome sequence of a blind myriapod, Strigamia maritima. The species is one of a group of venomous centipedes that are unusual in the way in which they care for their eggs. The research also provides new insights into the biological evolution of Strigamia maritima and its unique absence of vision and circadian rhythm.

The work was partly carried out and the sequencing completed at Baylor College of Medicine in Houston, Texas, and the findings have been published online in the journal PLOS Biology.

This is the first myriapod and the last of the four classes of arthropods to have its genome sequenced, said Dr. Stephen Richards, assistant professor in the Human Genome Sequencing Center at Baylor. Arthropods are particularly interesting for scientific study because they diverged into more species than any other animal group as they adapted in many ways to conquer the planet. The genome of the myriapod in comparison with previously completed genomes of the other arthropod classes gives us an important view of the evolutionary changes of these exciting species.

Other scientists involved in the study were Dr. Ariel Chipman, of the Hebrew University of Jerusalem in Israel, Dr. David Ferrier, of The University of St. Andrews in the United Kingdom, and Dr. Michael Akam of the University of Cambridge in the UK.

Chipman, associate professor at the Hebrew University, said that The arthropods have been around for over 500 million years and the relationship between the different groups and early evolution of the species is not really well understood. We have good sampling of insects but this is the first time a centipede, one of the more simple arthropods simple in terms of body plan, no wings, simple repetitive segments, etc. has been sequenced. This is a more conservative genome, not necessarily ancient or primitive, but one that has retained ancient features more than other groups.

Fossil evidence shows that the myriapods, along with insects and spiders, were one of three independent arthropod invasions of the land from the sea. To adapt to life on land they had to learn to smell chemicals in the air, rather than taste them in the water. The research did indeed discover evidence of large gene expansions of the gustatory receptors which are believed to perform the same olfactory role that olfactory receptors play in insects, Richards said. This is a nice example of parallel evolution where different group of genes expanded, providing a different solution to the same problem, he added.

The findings indicate that this centipede group lost its eyes at least 200 million years ago. No vision-specific genes or genes related to the circadian (or internal) clock were found in the genome.

See the article here:
Blind Scottish Centipede Genome Unlocks Evolutionary Secrets

Posted in Genome | Comments Off on Blind Scottish Centipede Genome Unlocks Evolutionary Secrets

Scientists completed the first orchid whole genome sequencing

Posted: at 1:46 pm

As one of the most diverse plant family, orchid now has its first genome sequenced and the result is published at Nature Genetics as a cover article.

This study is an accomplishment of the Orchid Genome Project, an international collaboration led by Lai-Qiang Huang and Zhong-Jian Liu at Tsinghua University and National Orchid Conservation Center in Shenzhen China, with colleagues from different institutions, including Chengkong University in Taiwan, Ghent University in Belgium, and Institute of Botany of CAS in Beijing.

The team carried out whole genome sequencing on phalaenopsis equestris, which is an important parental species for breeding of commercial phalaenopsis strains. P. equestris is also the first plant with Crassulacean Acid Metabolism (CAM) for which the genome has been sequenced. The assembled genome contains 29,431 predicted protein-coding genes. The average intron length is 2,922 base pairs, which is much longer than in any sequenced plant genomes. Further analysis indicate that transposable elements in introns are the major reason why orchid genes have so big introns.

As heterozygosity post great challenge for whole genome sequencing and assembly, the orchid genome is by no means an exception. In the orchid genome, they found that contigs likely to be under-assembled owing to heterozygosity, are enriched for genes that might be involved in self-incompatibility pathways. Those genes could be candidates for further research on the mechanism of self-incompatibility in orchid.

As in many plant genomes, they also found evidence for an orchid-specific paleopolyploidy event that preceded the radiation of most orchid clades. This is possibly an important clue to why orchid developed into one of the largest plant families on earth.

By comparing with homolog genes in other plant genomes, they found gene duplication and loss in CAM genes along the lineage to orchid. This result suggests that gene duplication might have contributed to the evolution of CAM photosynthesis in P. equestris.

Finally, they found expanded and diversified families of MADS-box C/D-class, B-class AP3 and AGL6-class genes, which might contribute to the highly specialized morphology of orchid flowers.

All around the world, orchids are highly endangered species because of illegal collection and habitat loss. The complete genome sequence of P. equestris will provide an important resource to explore orchid diversity and evolution at the genome level. The genome sequence will also be a key resource for the development of new concepts and techniques in genetic engineering, such as molecular marker-assisted breeding and the production of transgenic plants, which are necessary to increase the efficiency of orchid breeding and aid orchid horticulture research.

Story Source:

The above story is based on materials provided by ResearchSEA. Note: Materials may be edited for content and length.

Read the rest here:
Scientists completed the first orchid whole genome sequencing

Posted in Genome | Comments Off on Scientists completed the first orchid whole genome sequencing

Link between DNA transcription, disease-causing expansions

Posted: at 1:46 pm

Researchers in human genetics have known that long nucleotide repeats in DNA lead to instability of the genome and ultimately to human hereditary diseases such Freidreich's ataxia and Huntington's disease.

Scientists have believed that the lengthening of those repeats occur during DNA replication when cells divide or when the cellular DNA repair machinery gets activated. Recently, however, it became apparent that yet another process called transcription, which is copying the information from DNA into RNA, could also been involved.

A Tufts University study published online on November 20 in the journal Cell Reports by a research team lead by Sergei Mirkin, the White Family Professor of Biology at Tufts' School of Arts and Sciences, along with former graduate student Kartick Shah and graduate students Ryan McGuity and Vera Egorova, explores the relationship between transcription and the expansions of DNA repeats. It concludes that the active transcriptional state of a DNA segment containing a DNA repeat predisposes it for expansions. The print version of the study will be published on December 11.

"There are a great many simple repetitive motifs in our DNA, such as GAAGAAGAA or CGGCGGCGG," says Mirkin. "They are stable and cause no harm if they stay short. Occasionally, however, they start lengthening compulsively, and these uncontrollable expansions lead to dramatic changes in genome stability, gene expression, which can lead to human disease."

In their study, the researchers used baker's yeast to monitor the progress and the fundamental genetic machineries for transcription, replication and repair in genome functioning.

"The beauty of the yeast system is that it provides one with a practically unlimited arsenal of tools to study the mechanisms of genome functioning," says Mirkin. "We created genetic systems to track down expansions of the repeats that were positioned in either transcribed or non-transcribed parts of reporter genes."

After measuring the rate of repeat expansions in all these cases, the authors found that a repeat can expand under the condition when there is practically no transcription, but the likelihood of the expansion process is drastically (10-fold) higher when the reporter is transcriptionally active.

Surprisingly, however, transcription machinery does not need to physically pass through the repeat to stimulate its expansion. Thus, it is the active transcription state of the repeat-containing DNA segment, rather than RNA synthesis through the repeat that promotes expansions.

In the transcriptionally active state, DNA is packaged in chromatin more loosely than when it is transcriptionally inactive. More specifically, the density of nucleosomes along the transcribed DNA segment is significantly lower than that in the non-transcribed segment. This packaging of repetitive DNA within the transcribed areas gives much more room for DNA strand gymnastics, ultimately leading to repeat expansions.

Whatever the exact model, says Mirkin, the fact that expandable DNA repeats were always found in transcribed areas of our genome may not be that surprising after all.

Originally posted here:
Link between DNA transcription, disease-causing expansions

Posted in Genome | Comments Off on Link between DNA transcription, disease-causing expansions

Aveeno Moisturizing Bar – Aveeno Eczema Therapy Moisturizing Cream – Video

Posted: at 1:46 pm


Aveeno Moisturizing Bar - Aveeno Eczema Therapy Moisturizing Cream
http://bestandcheapoffer.com/Aveeno http://bestandcheapoffer.com/Aveeno-Baby-Lotion http://bestandcheapoffer.com/Aveeno-Products Aveeno Moisturizing Bar - Aveeno Eczema Therapy Moisturizing ...

By: Shawn Bioklund

Originally posted here:
Aveeno Moisturizing Bar - Aveeno Eczema Therapy Moisturizing Cream - Video

Posted in Eczema | Comments Off on Aveeno Moisturizing Bar – Aveeno Eczema Therapy Moisturizing Cream – Video

Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized

Posted: at 1:46 pm

Amgen Inc. (AMGN: Quote) and AstraZeneca plc's (AZN: Quote) phase III trial of psoriasis drug candidate Brodalumab has met its primary endpoint of achieving total clearance of skin disease when compared with placebo as well as Janssen Biotech Inc.'s approved drug Stelara.

The trial, dubbed AMAGINE-2, is the third and final pivotal study in the companies' phase III psoriasis program. Brodalumab is being co-developed by Amgen and AstraZeneca.

Top-line results from AMAGINE-1, comparing Brodalumab with placebo, were released in May 2014 while top-line results from AMAGINE-3, comparing Brodalumab with Stelara and placebo, were announced as recently as November 11, 2014.

The trials AMAGINE-2 and AMAGINE-3 are identical in design.

AMGN closed Tuesday's trading at $162.24, down 1.18%.

Exact Sciences Corp.'s (EXAS: Quote) Cologuard will be reimbursed at $502 per test, according to the final payment decision issued by the Centers for Medicare & Medicaid Services.

Cologuard is the first and only FDA-approved noninvasive stool DNA colorectal cancer screening test.

EXAS closed Tuesday's trading at $24.90, up 2.55%.

Intra-Cellular Therapies Inc. (ITCI: Quote) has enrolled the first patient in its phase III trial of ITI-007 for the treatment of schizophrenia.

The trial, dubbed ITI-007-301, is designed to enroll over 400 patients with an acutely exacerbated episode of schizophrenia who will be randomized to receive one of three treatments namely, 60 mg ITI-007, 40 mg ITI-007, or placebo in a 1:1:1 ratio. Top-line results from this trial could be available as early as the fourth quarter of 2015.

Continued here:
Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized

Posted in Psoriasis | Comments Off on Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized

Page 2,938«..1020..2,9372,9382,9392,940..2,9502,960..»